MENU
+Compare
DSKYF
Stock ticker: OTC
AS OF
May 21 closing price
Price
$25.52
Change
-$0.79 (-3.00%)
Capitalization
59.21B

DSKYF stock forecast, quote, news & analysis

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005... Show more

DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for DSKYF with price predictions
May 21, 2025

DSKYF's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for DSKYF turned positive on May 20, 2025. Looking at past instances where DSKYF's MACD turned positive, the stock continued to rise in of 62 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 20, 2025. You may want to consider a long position or call options on DSKYF as a result. In of 123 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

DSKYF moved above its 50-day moving average on May 19, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for DSKYF crossed bullishly above the 50-day moving average on April 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where DSKYF advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

DSKYF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DSKYF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for DSKYF entered a downward trend on April 29, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DSKYF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DSKYF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.663) is normal, around the industry mean (5.632). P/E Ratio (75.188) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (2.010) is also within normal values, averaging (3.004). Dividend Yield (0.007) settles around the average of (0.161) among similar stocks. P/S Ratio (6.410) is also within normal values, averaging (3.643).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

DSKYF paid dividends on June 19, 2018

Daiichi Sankyo Co., Ltd. DSKYF Stock Dividends
А dividend of $35.00 per share was paid with a record date of June 19, 2018, and an ex-dividend date of March 28, 2018. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Bristol-Myers Squibb Co (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).

Industry description

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

Market Cap

The average market capitalization across the Pharmaceuticals: Major Industry is 86.34B. The market cap for tickers in the group ranges from 72.83K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is CRXTQ at 72.83K.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was 3%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 0%. CHJTF experienced the highest price growth at 27%, while MAYNF experienced the biggest fall at -9%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -38%. For the same stocks of the Industry, the average monthly volume growth was 10% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 33
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 100
Profit Risk Rating: 77
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
DSKYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
3-5-1, Nihonbashi-honcho
Phone
+81 362251111
Employees
14887
Web
https://www.daiichisankyo.com